Nuvasive reported $295.28M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US USD 10.09B 319M
Atricure ATRC:US USD 83.25M 1.28M
Baxter International BAX:US USD 3.77B 27M
Becton, Dickinson and BDX:US USD 4.59B 175M
Boston Scientific BSX:US USD 3.24B 72M
Cardiovascular Systems CSII:US USD 59.67M 2.82M
Cooper Companies COO:US USD 848.1M 4.7M
Dexcom DXCM:US USD 769.6M 73.4M
Edwards Lifesciences EW:US USD 1.35B 29.3M
Globus Medical GMED:US USD 254.15M 9.5M
Haemonetics HAE:US USD 297.48M 36.03M
Hologic HOLX:US USD 1.07B 121M
Inogen INGN:US USD 105.39M 2.01M
Insulet PODD:US USD 340.8M 41.4M
Integra Lifesciences IART:US USD 385.19M 12.62M
Intuitive Surgical ISRG:US USD 1.66B 97.6M
Johnson & Johnson JNJ:US USD 23.71B 85M
Medtronic MDT:US USD 7.59B 214M
Merit Medical Systems MMSI:US USD 287.18M 7.8M
Nuvasive NUVA:US USD 295.28M 15.17M
Orthofix International OFIX:US USD 114M 4.07M
Stryker SYK:US USD 5.2B 723M
Tandem Diabetes Care TNDM:US USD 204.55M 4.28M
Teleflex TFX:US USD 686.79M 17.75M
Zimmer Biomet Holdings Inc ZBH:US USD 1.83B 155.3M